Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

MYCOBACTERIUM LEPRAE - ANVISA Registration 80502070067

Access comprehensive regulatory information for MYCOBACTERIUM LEPRAE in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80502070067 and manufactured by HAIN LIFESCIENCE GMBH. The registration is held by MOBIUS LIFE SCIENCE INDUSTRIA E COMERCIO DE PRODUTOS PARA LABORATORIOS LTDA with validity until Oct 22, 2028.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 3 companies making the same product including INSTITUTO DE BIOLOGIA MOLECULAR DO PARANÁ, MOBIUS LIFE SCIENCE INDÚSTRIA E COMERCIO DE PRODUTOS PARA LABORATÓRIOS LTDA, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
3 Competitors
3 Recent Registrations
80502070067
2 Related Devices
Registration Details
ANVISA Registration Number: 80502070067
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

GenoType LepraeDR VER 1.0
Risk Class III

Registration Details

80502070067

25351592147201801

04645160000149

Company Information

Germany
PT: ALEMANHA

Dates and Status

Oct 22, 2018

22/10/2028

09/18/2025 19:00:01

GenoType LepraeDR VER 1.0
Risk Class III

Registration Details

80502070067

25351592147201801

04645160000149

Dates and Status

Oct 22, 2018

22/10/2028

09/18/2025 19:00:01